期刊文献+

雌激素在阿尔茨海默病中神经保护作用的研究进展 被引量:2

Research Progress of NeuroprotectiveFunction of Estrogen in Alzheimer Disease
下载PDF
导出
摘要 阿尔茨海默病(AD)是一种常见的中枢神经系统变性疾病,其病理特征主要是在海马和颞叶皮质出现老年斑和神经纤维缠结。大量研究表明神经纤维缠结与Tau蛋白过度磷酸化有关,而β-淀粉样蛋白(Aβ)是老年斑的主要成分。大量临床和流行病学证据表明AD的发病有性别差异,绝经后的老年女性更容易发生AD,说明雌激素缺乏是AD的危险因素。因此,雌激素替代治疗AD日益受到人们的重视,该文就近年有关雌激素与AD神经保护机制及其替代治疗进行综述。 Alzheimer disease(AD) is a common degenerative diseases of the central nervous system, and its main pathological features is senile plaques and neurofibrillary tangles in the hippocampus and temporal cortex. Numerous studies show that the neurofibrillary tangles is related to Tau protein hyperphosphorylation, and B-amyloid( AB) is the main component of the senile plaques. A large number of clinical and epidemiological evidence show that there is a gender difference in the incidence of AD, women are more likely to develop AD after menopause, which indicates the lack of estrogen is a risk factor of AD. So people are paying more attention to estrogen replacement therapy for AD. Here is to make a review of AD neuroprotective mech- anism and hormone replacement therapy of estrogen.
出处 《医学综述》 2013年第17期3095-3097,共3页 Medical Recapitulate
关键词 雌激素 阿尔茨海默病 神经保护机制 激素替代治疗 Estrogen Alzheimer disease Neuroprotection mechanism Hormone replacement therapy
  • 相关文献

参考文献28

  • 1Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia:The EURODEM Studies. EURODEM Incidence Research Group [ J ]. Neurology, 1999,53 (9) :1992-1997.
  • 2Brann DW, Dhandapani K, Wakade C, et al. Neurotrophic and neuroprotective actions of estrogen : basic mechanisms and clinical implications [ J ]. Steroids, 2007,72 ( 5 ) : 381-405.
  • 3Suzuki S, Gerhold LM, BSttner M, et al. Estradiol enhances neuro- genesis following ischemic stroke through estrogen receptors alpha and beta[ J ]. J Comp Neurol,2007,500 (6) : 1064-1075.
  • 4Latlamme N, Nappi RE, Drolet G, et al. Expression and neuropepti- dergic characterization of estrogen receptors (ERalpha and ERbeta)throughout the rat brain: anatomical evidence of distinct roles of each subtype [ J ]. J Neurobiol, 1998,36 ( 3 ) : 357-378.
  • 5Shi HR, Zhu LQ, Wang SH, et al. 17 beta-estradiol attenuates glyco- gen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner[ J]. J Neural Transm, 2008,115 (6) : 879-888.
  • 6Pike C J, Carroll JC, Rosario ER, et al. Protective actions of sex steroid hormones in Alzheimer's diseas[ J ]Front Neuroendocrinol, 2009,30(2) :239-258.
  • 7Zhao L, Yao J, Mao Z, et al. 1713-Estradiol regulates insulin- degrading enzyme expression via an ER/PI3-K pathway in hippo- campus : relevance to Alzheimer's prevention [ J ]. Neurobiol Aging, 2011,32( 11 ) :1949-1963.
  • 8Szego EM, Kekesi KA, Szabo Z,et al. Estrogen regulates eytoskeletal flexibility, cellular metabolism and synaptic proteins: a proteomic study[ J]. Psychoneuroendocrinology,2010,35 (6) :807-819.
  • 9Nilsen J. Estradiol and neurodegenerative oxidative stress [ J ]. Front Neuroendocrinol, 2008,29 ( 4 ) :463 -475.
  • 10Struble RG, Nathan BP, Cady C,et al. Estradiol regulation of astro- glia and apolipoprotein E:an important role in neuronal regenera- tion[ J]. Exp Geronto1,2007 ,42(1/2) :54-63.

同被引文献55

  • 1庄莹,陈杰.阿尔茨海默病病因及发病机制研究进展[J].吉林医药学院学报,2008,29(2):101-104. 被引量:23
  • 2陈怡,李明,王庆山.白藜芦醇对中枢神经系统保护作用的研究进展[J].武警医学,2006,17(10):780-782. 被引量:6
  • 3Brisdelli FD. Andrea, G. Bozzi A. Resveratrol: a natural polyphenol with multiple chemopreventive properties [ ] ]. Curt Drug Metab,2009. 10(6) :530.
  • 4Rodrigo R, Miranda A, Vergara L. Modulation of endogenous antioxi- dant system by wine polyphenols in human disease[ J]. Clin Chim Ac- ta,2011. 412(5 -6) : 410.
  • 5J Ferri'eres. The French paradox: lessons for other countries[J]. Heart, 2004,90( 1 ) : 107.
  • 6Baur JA, Pearson K J, Price NL, et al. Resveratrol improves health and survival of mice on a high - calorie diet[J]. Nature, 2006,444 ( 7117 ) : 337.
  • 7Jung KH, Lee JH, Park JW , etal. Resveratrol - loaded polymeric nano- particles suppress glucose metabolism and tumor growth in vitro and in vivo[J].Int J Pharm,2014,478 ( 1 ) :251.
  • 8Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity[J].Antioxid Redox Signal,2009,11 ( 11 ) : 2851.
  • 9Lijima K ,Gatt A,Lijima -Ando K. Tan Ser262 phosphorylationis criti- cal For Abeta42 - induced tan toxicity in a transgenic Drosophila model of Alzheimer disease[ J]. Hum Mol Genet,2010,19(15) :2947.
  • 10Wang J, Bi W, Cheng A, et al. Targeting muhiple pathogenic mecha- nisms with polyphenols for the treatment of Alzheimerg disease - experi- mental approach and therapeutic implications [ J ]. FrontAging Neuros- ci,2014,42(6) :I.

引证文献2

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部